Gary Charles Robb
Net Worth
Last updated:
What is Gary Charles Robb net worth?
The estimated net worth of Mr. Gary Charles Robb is at least $19,386,924 as of 22 Nov 2024. He owns shares worth $1,431,573 as insider, has earned $11,590,391 from insider trading and has received compensation worth at least $6,364,960 in Corcept Therapeutics Incorporated.
What is the salary of Gary Charles Robb?
Mr. Gary Charles Robb salary is $795,620 per year as Chief Bus. Officer & Sec. in Corcept Therapeutics Incorporated.
How old is Gary Charles Robb?
Mr. Gary Charles Robb is 62 years old, born in 1963.
What stocks does Gary Charles Robb currently own?
As insider, Mr. Gary Charles Robb owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Corcept Therapeutics Incorporated (CORT) | Chief Bus. Officer & Sec. | 20,163 | $71 | $1,431,573 |
What does Corcept Therapeutics Incorporated do?
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.
Gary Charles Robb insider trading
Corcept Therapeutics Incorporated
Mr. Gary Charles Robb has made 29 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,609 units of CORT stock worth $146,626 on 22 Nov 2024.
The largest trade he's ever made was exercising 451,852 units of CORT stock on 22 Jan 2021. As of 22 Nov 2024 he still owns at least 20,163 units of CORT stock.